TILT Holdings (TLLTF) Net Income towards Common Stockholders (2021 - 2025)

TILT Holdings (TLLTF) reported Net Income towards Common Stockholders of -$9.2 million for Q2 2025, up 44.71% on a YoY basis from -$6.3 million in Q2 2024, and up 30.88% quarter-over-quarter from -$13.2 million in Q1 2025.

TILT Holdings (TLLTF) Net Income towards Common Stockholders (2021 - 2025) Analysis & Trends

TILT Holdings has reported Net Income towards Common Stockholders for 5 years, with the latest figure at -$9.2 million in Q2 2025.

  • For the quarter ending Q2 2025, Net Income towards Common Stockholders rose 44.71% year-over-year to -$9.2 million; the trailing twelve-month figure through Jun 2025 stood at -$71.7 million (down 17.95% YoY), and the FY2024 full-year result was -$94.9 million, down 39.99% from the prior year.
  • Net Income towards Common Stockholders for Q2 2025 stood at -$9.2 million, up from -$13.2 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $1.0 million in Q2 2021, with the low at -$71.6 million in Q4 2022.
  • Historically, Net Income towards Common Stockholders has averaged -$17.0 million across 5 years, with a median of -$12.6 million in 2024.
  • Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders sank 1629.34% — and 2023, when it soared 63.76%.
  • TILT Holdings' Net Income towards Common Stockholders stood at -$20.1 million in 2021, then tumbled by 255.85% to -$71.6 million in 2022, then jumped by 63.76% to -$26.0 million in 2023, then plunged by 41.37% to -$36.7 million in 2024, then soared by 75.06% to -$9.2 million in 2025.
  • The last three Net Income towards Common Stockholders figures came in at -$9.2 million (Q2 2025), -$13.2 million (Q1 2025), and -$36.7 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 366.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 1.99 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -92.12 Mn
10 TILT Holdings - - 1.82 Mn -9.15 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 -9.15 Mn
Mar 31, 2025 -13.24 Mn
Dec 31, 2024 -36.70 Mn
Sep 30, 2024 -12.65 Mn
Jun 30, 2024 -16.55 Mn
Mar 31, 2024 -9.65 Mn
Dec 31, 2023 -25.96 Mn
Sep 30, 2023 -8.66 Mn
Jun 30, 2023 -28.34 Mn
Mar 31, 2023 -4.87 Mn
Dec 31, 2022 -71.63 Mn
Sep 30, 2022 -15.69 Mn
Jun 30, 2022 -7.05 Mn
Mar 31, 2022 -11.63 Mn
Dec 31, 2021 -20.13 Mn
Sep 30, 2021 1.03 Mn
Jun 30, 2021 1.03 Mn